Recent advances in the understanding and treatment of acute myeloid leukemia

about

Recent advances in the understanding and treatment of acute myeloid leukemia

Item

http://www.wikidata.org/entity/Q58799330

description

scientific article published on 06 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Recent advances in the understanding and treatment of acute myeloid leukemia

@en

Recent advances in the understanding and treatment of acute myeloid leukemia

@nl

type

Item

label

Recent advances in the understanding and treatment of acute myeloid leukemia

@en

Recent advances in the understanding and treatment of acute myeloid leukemia

@nl

prefLabel

Recent advances in the understanding and treatment of acute myeloid leukemia

@en

Recent advances in the understanding and treatment of acute myeloid leukemia

@nl

P1476

Recent advances in the understanding and treatment of acute myeloid leukemia

@en

P2093

Stephen Nimer

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Arginine methyltransferases in normal and malignant hematopoiesis

Protein lysine acetylation by p300/CBP

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation.

The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

P304

1196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.14116.1

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Justin Watts

P577

2018-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30135719

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

6081972

http://www.w3.org/2001/XMLSchema#string